Skip to main content
. 2022 Sep 12;19(9):e1004097. doi: 10.1371/journal.pmed.1004097

Fig 2. PrEP Cascade.

Fig 2

(A) All participants. (B) Participants with detectable TFV-DP levels (10+ fmol/punch) at the first Interview. T1: first interview visit (Time point 1). T2: second interview visit (Time point 2). The numbers of participants in the categories of TFV-DP levels are shown in S1 Table. PrEP, pre-exposure prophylaxis; TFV-DP, tenofovir-diphosphate.